Title Category Credit Event datesort ascending Cost
EM2006F "Slaying the Hydra: Recurrent Clostridioides difficile infections" (IM GR-062620)
  • AMA
$0.00 The purpose of this presentation is to acquaint the viewers with recent advances in the treatment and prevention of recurrent Clostridioides difficile infections (rCDI). The presentation will begin with a review of the pathogenesis and epidemiology of rCDI, followed by discussion of newer agents available to treat rCDI (fidaxomicin, bezlotoxumab), and will conclude with remarks on the current state of fecal microbiota transplantation (FMT), generally and at UT Southwestern Medical Center.
Coffee, Kids and Sports Medicine - 'Impact of COVID-19 on Physical Activity and Mental Health in Youth' (EM2007X)
  • AMA
  • Attendance